Coronary Artery Restenosis Completed Phase 2 Trials for Bindarit (DB12739)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01269242The Effects of Bindarit in Preventing Stent RestenosisPrevention